Article Details

Xeris Stock Jumps on FDA Clearance of Hypoglycemia Treatment - TheStreet

Retrieved on: 2021-08-23 14:48:45

Tags for this article:

Click the tags to see associated articles and topics

Xeris Stock Jumps on FDA Clearance of Hypoglycemia Treatment - TheStreet. View article details on hiswai:

Excerpt

Earlier this year, Xeris agreed to acquire Strongbridge Biopharma in a deal that valued the company at $267 million. Under the terms of the agreement, ...

Article found on: www.thestreet.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up